Focal task-specific dystonia (FTSD) poses a complex interplay of maladaptive neuroplasticity and motor-circuit imbalance. Traditional theories often implicate subcortical nuclei but fail to explain why symptoms remain so tightly bound to a singular, highly practiced skill. Here, we propose that the primary driver of FTSD is a newly formed “dystonic synergy” within the primary motor cortex (M1), in which excitatory circuit synapses are adequate relative to under-strengthened inhibitory circuit synapses, triggering involuntary contractions once the skill’s intensity demands surpass the functional synergy’s excitatory and inhibitory circuit capacity (synaptic strength). In short, we use an extensive single-case observation as the core empirical foundation, we chronicle how a decade of stable piano performance deteriorated following a sudden technical change that forced the finger flexion motor synergy to “overreach”. The patient’s initial phase was dominated by “true weakness,” a condition of task-specific paresis where the motor system is physically unable to generate the required excitatory/inhibitory (E/I) drive to match the attempted movement speed; over repetitive attempts to override that limitation, the excitatory circuit strengthened while the inhibitory circuit lagged, culminating in a fully formed dystonic synergy within three weeks. This maladaptive synergy then manifested in both piano playing and typing—a related digit-based skill—greatly disabling normal function in both tasks. We illustrate that once formed, the dystonic synergy remains stable but not spontaneously progressive, consistent with a saturable excitatory capacity. Moreover, we used a spiking neural network simulation to provide quantitative proof of concept verification of the hypothesis. Other commonly reported structural or electrophysiological alterations—such as basal ganglia and cerebellar changes, sensorimotor smudging in the primary somatosensory cortex (S1), or impaired spinal inhibition—are reframed and proposed as secondary byproducts emerging from chronic hyperexcitation of the M1 synergy. Additionally, we outline a new taxonomy distinguishing (i) “typical” neuroplastic dystonias, including task-specific forms whose primary trigger is repeated overreaching and whose pathophysiology lies in the consequent synergy imbalance; (ii) atypical neuroplastic variants with strong genetic underpinnings but partial plastic compensation; and (iii) non-neuroplastic dystonias resulting from more deterministically causal gene mutations. Finally, we propose and describe a non-invasive motor retraining approach for reversing FTSD: “below or at-threshold retraining” (BATR), wherein the inhibitory circuit of the dystonic synergy is methodically strengthened. This motor strategy, validated in the single-case longitudinal data alongside other published studies using very similar methods, reveals that the dysregulated synergy can be rebalanced to restore fully normal motor function. By integrating these mechanistic and therapeutic insights, we offer a unifying framework for FTSD pathogenesis and highlight a compelling, noninvasive avenue for cure alongside a guided strategy for prevention.